Company Overview
Created in July 2006, its ambition is to federate all stakeholders from Wallonia participating in innovation and training in the fields of biotechnologies and medical technologies.
BioWin brings together 195 company members including 10 global leaders (Alten, Baxter, GSK, IBA, IMEC, IRE, Kaneka-Eurogentec, UCB, XPE Pharma & Sciences and Zoetis ), 185 innovative SMEs, 5 private research centres, 5 universities (UCLouvain, ULB, ULi├Ęge, UMons & UNamur) fitted with 400 research units, 11,000 researchers and 3 university hospitals.
BioWin members are active in the following key strategic domains:
(Bio)pharmacy
Cell therapy
Biomanufacturing
Medical devices and in vitro diagnostics
Radiation applied to health
Data science